Atlas Trials

TEPH: Telaglenastat Efficacy in Pulmonary Hypertension

Clinical trial NCT07223528 · NOT_YET_RECRUITING

Trial details

NCT number
NCT07223528
Sponsor
Chan, Stephen, MD, PhD
Status
NOT_YET_RECRUITING
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Pulmonary Hypertension
Start date
2026-08-01
Primary completion
2028-09-01
Enrollment
28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.